346 related articles for article (PubMed ID: 23183445)
1. A novel electrostatic dry coating process for enteric coating of tablets with Eudragit® L 100-55.
Qiao M; Zhang L; Ma Y; Zhu J; Xiao W
Eur J Pharm Biopharm; 2013 Feb; 83(2):293-300. PubMed ID: 23183445
[TBL] [Abstract][Full Text] [Related]
2. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
Sauer D; Zheng W; Coots LB; McGinity JW
Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
[TBL] [Abstract][Full Text] [Related]
3. Sustained release coating of tablets with Eudragit(®) RS/RL using a novel electrostatic dry powder coating process.
Qiao M; Luo Y; Zhang L; Ma Y; Stephenson TS; Zhu J
Int J Pharm; 2010 Oct; 399(1-2):37-43. PubMed ID: 20678560
[TBL] [Abstract][Full Text] [Related]
4. A novel electrostatic dry powder coating process for pharmaceutical dosage forms: immediate release coatings for tablets.
Qiao M; Zhang L; Ma Y; Zhu J; Chow K
Eur J Pharm Biopharm; 2010 Oct; 76(2):304-10. PubMed ID: 20600889
[TBL] [Abstract][Full Text] [Related]
5. Influence of additives on melt viscosity, surface tension, and film formation of dry powder coatings.
Sauer D; McGinity JW
Drug Dev Ind Pharm; 2009 Jun; 35(6):646-54. PubMed ID: 19337869
[TBL] [Abstract][Full Text] [Related]
6. Properties of theophylline tablets dry powder coated with Eudragit E PO and Eudragit L 100-55.
Sauer D; McGinity J
Pharm Dev Technol; 2009; 14(6):632-41. PubMed ID: 19883252
[TBL] [Abstract][Full Text] [Related]
7. Eudragit(®) RS PO/RL PO as rate-controlling matrix-formers via roller compaction: Influence of formulation and process variables on functional attributes of granules and tablets.
Dave VS; Fahmy RM; Bensley D; Hoag SW
Drug Dev Ind Pharm; 2012 Oct; 38(10):1240-53. PubMed ID: 22257339
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the film formation of the dry coating process.
Kablitz CD; Urbanetz NA
Eur J Pharm Biopharm; 2007 Sep; 67(2):449-57. PubMed ID: 17451928
[TBL] [Abstract][Full Text] [Related]
9. The manufacture and characterisation of hot-melt extruded enteric tablets.
Andrews GP; Jones DS; Diak OA; McCoy CP; Watts AB; McGinity JW
Eur J Pharm Biopharm; 2008 May; 69(1):264-73. PubMed ID: 18164604
[TBL] [Abstract][Full Text] [Related]
10. Applying a novel electrostatic dry powder coating technology to pellets.
Yang Q; Ma Y; Zhu J
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
[TBL] [Abstract][Full Text] [Related]
11. Moisture plasticization for enteric Eudragit® L30D-55-coated pellets prior to compression into tablets.
Rujivipat S; Bodmeier R
Eur J Pharm Biopharm; 2012 May; 81(1):223-9. PubMed ID: 22269937
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical properties of enteric films prepared from aqueous dispersions and organic solutions.
Bando H; McGinity JW
Int J Pharm; 2006 Apr; 313(1-2):43-8. PubMed ID: 16487672
[TBL] [Abstract][Full Text] [Related]
13. Influence of plasticizer level on the drug release from sustained release film coated and hot-melt extruded dosage forms.
Zhu Y; Mehta KA; McGinity JW
Pharm Dev Technol; 2006; 11(3):285-94. PubMed ID: 16895839
[TBL] [Abstract][Full Text] [Related]
14. Relationship between drug dissolution and leaching of plasticizer for pellets coated with an aqueous Eudragit S100:L100 dispersion.
Bando H; McGinity JW
Int J Pharm; 2006 Oct; 323(1-2):11-7. PubMed ID: 16815652
[TBL] [Abstract][Full Text] [Related]
15. Citric acid as a solid-state plasticizer for Eudragit RS PO.
Schilling SU; Shah NH; Malick AW; Infeld MH; McGinity JW
J Pharm Pharmacol; 2007 Nov; 59(11):1493-500. PubMed ID: 17976259
[TBL] [Abstract][Full Text] [Related]
16. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
17. Near-infrared spectroscopic analysis of the breaking force of extended-release matrix tablets prepared by roller-compaction: influence of plasticizer levels and sintering temperature.
Dave VS; Fahmy RM; Hoag SW
Drug Dev Ind Pharm; 2015 Jun; 41(6):898-905. PubMed ID: 24785574
[TBL] [Abstract][Full Text] [Related]
18. Solid-state plasticization of an acrylic polymer with chlorpheniramine maleate and triethyl citrate.
Zhu Y; Shah NH; Malick AW; Infeld MH; McGinity JW
Int J Pharm; 2002 Jul; 241(2):301-10. PubMed ID: 12100857
[TBL] [Abstract][Full Text] [Related]
19. Dry coating in a rotary fluid bed.
Kablitz CD; Harder K; Urbanetz NA
Eur J Pharm Sci; 2006 Feb; 27(2-3):212-9. PubMed ID: 16290285
[TBL] [Abstract][Full Text] [Related]
20. Optimised process and formulation conditions for extended release dry polymer powder-coated pellets.
Terebesi I; Bodmeier R
Eur J Pharm Biopharm; 2010 May; 75(1):63-70. PubMed ID: 20079833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
